Trials / Unknown
UnknownNCT03269279
Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina Faso
Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy (13-22 Weeks LMP) in Burkina Faso
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Gynuity Health Projects · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
The goal of this study is to examine the effectiveness and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Burkina Faso.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mifepristone | Medication used in conjunction with misoprostol for abortion |
| DRUG | Misoprostol | Medication used in conjunction with mifepristone for abortion |
Timeline
- Start date
- 2017-05-20
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2017-08-31
- Last updated
- 2019-05-30
Locations
4 sites across 1 country: Burkina Faso
Source: ClinicalTrials.gov record NCT03269279. Inclusion in this directory is not an endorsement.